ACEA Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ACEA Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6450
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ACEA Biosciences Inc (ACEA) is a biotechnology company that development and commercialization of cell analysis instruments for life science research and clinical diagnostics. The company’s products include impedance-based, label-free, and real-time cell analysis systems, benchtop flow cytometers, RTCA SP instruments, RTCA HT instrument and RTCA MP instrument, among others. ACEA’s products are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research and development. The company markets its products in Canada, Austria, Belarus, Denmark, Finland, Greece, Germany, Italy, Poland, Portugal, Russia, India, China, New Zealand, Singapore, the Philippines, the UK and the US, among others. ACEA is headquartered in San Diego, California, the US.

ACEA Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ACEA Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ACEA Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ACEA Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ACEA Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ACEA Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ACEA Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
ACEA Biosciences Raises USD30 Million in Venture Financing 10
Partnerships 11
ACEA Biosciences and Ncardia Enter into Partnership 11
ACEA Biosciences and Memorial Sloan Kettering Cancer Center Enter into Agreement 12
Acquisition 13
Agilent Technologies to Acquire ACEA Biosciences for USD250 Million 13
ACEA Biosciences Inc – Key Competitors 14
ACEA Biosciences Inc – Key Employees 15
ACEA Biosciences Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Product News 17
Apr 27, 2018: Novel Assay Monitors Kinetics of Cell Migration in High Throughput Format 17
Dec 18, 2017: Real-Time Monitoring of Melanoma Cell Invasion Helps Scientists Elucidate Key Regulators of Metastasis 18
Dec 14, 2017: Viral Vaccine Development Gets Major Boost from xCELLigence RTCA 19
Dec 08, 2017: Oncolytic Adenovirus Expressing BiTE Effectively Recruits T Cells to Kill Diverse Cancer Cell Types 20
May 03, 2017: ACEA Biosciences Introduces a Multi-Option Configuration NovoCyte Flow Cytometer 21
Apr 07, 2017: Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around the World 22
Other Significant Developments 23
Sep 20, 2018: ACEA Biosciences Releases New Version of NovoExpress Flow Cytometry Software. 23
Dec 28, 2017: Live Cell Analysis Using xCELLigence Instruments: Searchable Library of Over 1,400 Publications Now Online 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
ACEA Biosciences Inc, Medical Equipment, Key Facts 2
ACEA Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ACEA Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ACEA Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ACEA Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ACEA Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
ACEA Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ACEA Biosciences Raises USD30 Million in Venture Financing 10
ACEA Biosciences and Ncardia Enter into Partnership 11
ACEA Biosciences and Memorial Sloan Kettering Cancer Center Enter into Agreement 12
Agilent Technologies to Acquire ACEA Biosciences for USD250 Million 13
ACEA Biosciences Inc, Key Competitors 14
ACEA Biosciences Inc, Key Employees 15
ACEA Biosciences Inc, Subsidiaries 16

List of Figures
ACEA Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ACEA Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ACEA Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ACEA Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ACEA Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ACEA Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ACEA Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ACEA Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ACEA Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Liuzhou Liangmianzhen Co., Ltd. (600249):企業財務及び戦略的SWOT分析
    Summary Liuzhou Liangmianzhen Co., Ltd. (Liuzhou) is a home care products manufacturer based in China. The company offers personal care, home care and oral care products. Its oral care products include tooth paste, mouth wash and tooth brush. The company’s personal care products include shampoo, bod …
  • Wellington Management Company LLP:企業の戦略・SWOT・財務情報
    Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report Summary Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Tata Group:企業概要及び戦略的SWOT分析
    Tata Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • PUMA SE:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PUMA SE Mergers and Acquisition …
  • The Valspar Corporation (VAL):企業の財務及び戦略的SWOT分析
    The Valspar Corporation (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Enzymatica AB (ENZY):企業のM&A・提携動向(医療機器分野)
    Summary Enzymatica AB (Enzymatica) is a biotechnology company that offers development and marketing of medical products. The company offers products which include mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and dental …
  • Fidelity Bank Plc:企業の戦略・SWOT・財務情報
    Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bright Food (Group) Co., Ltd.:企業のM&A・提携・投資分析
    Bright Food (Group) Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bright Food (Group) Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Lantheus Medical Imaging, Inc.:企業の戦略的SWOT分析
    Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Essar Oil Ltd.の企業概要及び財務/SWOT分析
    Essar Oil Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Essar Oil Ltd. annual and quarterly forecasts made by stock market experts. The report also enables direct comp …
  • Ashuganj Power Station Company Ltd.:企業のM&A・提携動向(エネルギー分野)
    Summary Ashuganj Power Station Company Ltd. (APSCL) is a power company which generates and distributes electricity to various customers. The company generates electricity through two thermal power plants and combined cycle power plant. APSCL operates through seven generating units comprising five st …
  • GLP J-REIT:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "GLP J-REIT" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a stan …
  • The Priceline Group Inc.:企業の戦略・SWOT・財務分析
    SummaryThe Priceline Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Alerus Financial Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alerus Financial Corporation Me …
  • Noile-Immune Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noile-Immune Biotech Inc (Noile-Immune Biotech) is a clinical stage biotechnology company that develops and commercializes next generation CAR-T cell therapies for the treatment of cancer. The company works in collaboration with National Cancer Center Japan and Yamaguchi University to develo …
  • Tervita Corp:企業の戦略・SWOT・財務情報
    Tervita Corp - Strategy, SWOT and Corporate Finance Report Summary Tervita Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Imperial College London:企業のM&A・事業提携・投資動向
    Imperial College London - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imperial College London Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Heat Biologics, Inc. (HTBX):企業の財務及び戦略的SWOT分析
    Summary Heat Biologics, Inc. (Heat Biologics) is a clinical-stage biopharmaceutical company that develops therapies. The company develops Immune Pan-Antigen Cytotoxic Therapy, a therapeutic vaccine used in the treatment of a wide range of cancers and infectious diseases. Heat Biologics pipeline prod …
  • The Dow Chemical Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Dow Chemical Company Merger …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆